Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer
详细信息    查看全文
  • 作者:J. López Torrecilla (1)
    A. Zapatero (2)
    I. Herruzo (3)
    F. A. Calvo (4)
    M. A. Cabeza (5)
    A. Palacios (6)
    A. Guerrero (7)
    A. Hervás (8)
    P. Lara (9)
    B. Lude?a Martínez (10)
    E. del Cerro Pe?alver (11)
    G. Nagore (12)
    G. Sancho (13)
    J. L. Mengual (14)
    M. Mira (15)
    A. Mairi?o (16)
    P. Samper (17)
    S. Pérez (18)
    I. Castillo (19)
    J. C. Martínez Cedrés (20)
    E. Ferrer (21)
    S. Rodriguez (22)
    X. Maldonado (23)
    A. Gómez Caama?o (24)
    C. Ferrer (25)
  • 关键词:Radiotherapy ; Infrastructure ; Workload ; Prostate cancer
  • 刊名:Clinical and Translational Oncology
  • 出版年:2014
  • 出版时间:May 2014
  • 年:2014
  • 卷:16
  • 期:5
  • 页码:447-454
  • 全文大小:328 KB
  • 参考文献:1. Comisión de las Sociedades Oncológicas para la Planificación Oncológica en Espa?a Libro Blanco de la Oncología en Espa?a. Informe para la Planificación global de la Oncología. Ed. Jims, Barcelona; 1988.
    2. López-Torrecilla J, Guedea F, Heeren G, Nissin R, Ellison T, Cottier B. Patterns of care for brachytherapy in Europe. Results in Spain. Clin Transl Oncol. 2006;8(5):362-. CrossRef
    3. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18(3):581-2. mdl498" target="_blank" title="It opens in new window">CrossRef
    4. Zapatero A, López-Torrecilla J, Herruzo I, Calvo FA, SEOR URONCOR GICOR participating Investigators. Practice patterns in the management of prostate cancer in Spain: results from a national survey among radiation oncologists in 2009. Clin Transl Oncol. 2013;15(3):226-2. CrossRef
    5. Zapatero A, Valcarcel F, Calvo FA, Alga’s R, Béjar A, Maldonado J, et al. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study. J Clin Oncol. 2005;23(27):6561-. CrossRef
    6. Slotman BJ, Cottier B, Bentzen SM, Heeren G, Lievens Y, van den Bogaert W. Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: workpackage 1. Radiother Oncol. 2005;75(3):349-4. CrossRef
    7. Porter A, Aref A, Chodounsky Z, Elzawawy A, Manatrakul N, Ngoma T, et al. A global strategy for radiotherapy: a WHO consultation. Clin Oncol (R Coll Radiol). 1999;11:368-0.
    8. Herruzo Cabrera I, Espinosa Calvo M, López-Torrecilla J, Maciá Garau M, Palacios Eito A, Sánchez Calzado J, et al. Cálculo de necesidades e infraestructura en Espa?a. In: Libro Blanco SEOR-XXI. Análisis de la situación, necesidades y recursos de la Oncología Radioterápica. Editores Médicos, SA. EDIMSA, Madrid; 2010;65-5.
    9. Martínez García C, Sánchez Pérez MJ, Borrás-i-Andrés JM. El Cáncer en Espa?a: Epidemiología descriptiva in: Libro Blanco SEOR-XXI. Análisis de la situación, necesidades y recursos de la Oncología Radioterápica. Editores Médicos, SA. EDIMSA. Madrid; 2010;9-0.
    10. Cortes F, Díaz R, García V, Herranz C, Martinez C, Mu?oz Villa A, et al. Segundo Libro Blanco de la Oncología Espa?ola. ENE Publicidad; Madrid; 1995.
    11. Palacios Eito A, Espinosa Calvo M, Ma?as Rueda A, de las Heras González M. Equipamiento y necesidades futuras. Situación actual en Espa?a. Revisiones en Cáncer 2006;20(5):205-2.
    12. Esco R, Palacios A, Pardo J, Biete A, Carceller JA, Veiras C, et al. Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources. Int J Radiat Oncol Biol Phys. 2003;56(2):319-7. CrossRef
    13. Larra?aga N, Galceran J, Ardanaz E, Franch P, Sánchez MJ, Pastor-Barriuso R, et al. Prostate cancer incidence trends in Spain before and during the prostate-specific antigen era: impact on mortality. Ann Oncol. 2010;21(Suppl 3):iii83-.
    14. Guedea F, Venselaar J, Hoskin P, Hellebust TP, Peiffert D, Londres B, et al. Patterns of care for brachytherapy in Europe: updated results. Radiother Oncol. 2010;97(3):514-0. CrossRef
    15. Ruggieri-Pignon S, Pignon T, Marty M, Rodde-Dunet MH, Destembert B, Fritsch B. Infrastructure of radiation oncology in France: a large survey of evolution of external beam radiotherapy practice. Int J Radiat Oncol Biol Phys. 2005;61(2):507-6. CrossRef
    16. Jetne V, Kval?y S, Smeland S, Johannesen TB, Tveit KM. Use of radiotherapy in South-Eastern Norway Regional Health Authority. Tidsskr Nor Laegeforen. 2009 17;129(24):2602-.
    17. Ringborg U, Bergqvist D, Brorsson B, Cavallin-St?hl E, Ceberg J, Einhorn N, et al. The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001—summary and conclusions. Acta Oncol. 2003;42(5-):357-5. CrossRef
    18. Delaney GP, Jacob S, Featherstone C, Barton M. Radiotherapy in cancer care: estimating optimal utilisation from a review of evidence-based clinical guidelines. Collaboration for Cancer Outcomes Research and Evaluation (CCORE). Liverpool Hospital; Sydney; 2003.
    19. Tyldesley S, Delaney G, Foroudi F, Barbera L, Kerba M, Mackillop W. Estimating the need for radiotherapy for patients with prostate, breast, and lung cancers: verification of model estimates of need with radiotherapy utilization data from British Columbia. Int J Radiat Oncol Biol Phys. 2011;79(5):1507-5. CrossRef
    20. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents, Vol. IX. IARC Scientific Publications No 160, Lyon: IARC, 2007 Board of the Faculty of Clinical Oncology. Equipment, workload and staffing for radiotherapy in the UK 1997-002. London: The Royal College of Radiologists; 2003.
  • 作者单位:J. López Torrecilla (1)
    A. Zapatero (2)
    I. Herruzo (3)
    F. A. Calvo (4)
    M. A. Cabeza (5)
    A. Palacios (6)
    A. Guerrero (7)
    A. Hervás (8)
    P. Lara (9)
    B. Lude?a Martínez (10)
    E. del Cerro Pe?alver (11)
    G. Nagore (12)
    G. Sancho (13)
    J. L. Mengual (14)
    M. Mira (15)
    A. Mairi?o (16)
    P. Samper (17)
    S. Pérez (18)
    I. Castillo (19)
    J. C. Martínez Cedrés (20)
    E. Ferrer (21)
    S. Rodriguez (22)
    X. Maldonado (23)
    A. Gómez Caama?o (24)
    C. Ferrer (25)

    1. Department of Radiation Oncology-ERESA, Hospital General Universitario, Avda. Tres Cruces 2, 46007, Valencia, Spain
    2. Department of Radiation Oncology, Hospital Universitario de la Princesa, C. de Diego de León 62, 28006, Madrid, Spain
    3. Department of Radiation Oncology, Hospital Universitario Carlos Haya, Avda. Carlos Haya, s/n, 29010, Málaga, Spain
    4. Department of Oncology, Hospital Universitario Gregorio Mara?ón, C. de Maiquez 7, 28009, Madrid, Spain
    5. Hospital Universitario 12 de Octubre, Avda. de Córdoba, s/n, 28041, Madrid, Spain
    6. Hospital Universitario Reina Sofía, Avda. Menéndez Pidal, s/n, 14004, Córdoba, Spain
    7. Hospital Universitari Son Dureta, C. d’Andrea Dòria 55, 07014, Palma, Spain
    8. Hospital Universitario Ramón y Cajal, C. San Modesto 50, 28034, Madrid, Spain
    9. Hospital Universitario de Gran Canaria Dr. Negrín, Barranco de la Ballena, s/n, 35010, Las Palmas de Gran Canaria, Spain
    10. Hospital Universitario de Fuenlabrada, C. Camino del Molino 2, 28942, Fuenlabrada, Spain
    11. Hospital Quirón de Madrid, C. de Juan Bravo 39, 28006, Madrid, Spain
    12. Instituto Alicantino de Oncología-Grupo IMO, Sanatorio del Perpetuo Socorro, C. Vázquez de Mella 26, 03013, Alicante, Spain
    13. Hospital de la Santa Creu i Sant Pau, C. Sant Quintí 89, 08026, Barcelona, Spain
    14. Instituto Valenciano de Oncología, C. del Profesor Beltrán Bàguena 8, 46009, Valencia, Spain
    15. Hospital Universitari Arnau de Vilanova, Avda. Alcalde Rovira Roure 80, 25198, Lleida, Spain
    16. Centro Oncológico de Galicia, Complejo Hospitalario Universitario de A Coru?a, C. Doctor Camilo Veiras 1, 15009, A Coru?a, Spain
    17. Hospital Central de la Defensa “Gómez Ulla- Glorieta del Ejercito 1, 28047, Madrid, Spain
    18. Hospital Marqués de Valdecilla, Avda Valdecilla, s/n, 39008, Santander, Spain
    19. Hospital Clínico Universitario San Cecilio, Avda. Dr. Olóriz 16, 18012, Granada, Spain
    20. Hospital Universitario Nuestra Se?ora de la Candelaria, Carretera del Rosario 145, 38010, Santa Cruz de Tenerife, Spain
    21. Hospital Clínico Universitario de Valencia, Avda. de Blasco Ibá?ez 17, 46010, Valencia, Spain
    22. Hospital Clínica Benidorm, Avda. Alfonso Puchades 8, 03501, Benidorm, Spain
    23. Hospital Vall D’Hebron, Passeig Vall d’Hebron, 119-129, 08035, Barcelona, Spain
    24. Hospital Clínico Universitario de Santiago de Compostela, Travesía de Choupana, s/n, 15706, Santiago de Compostela, Spain
    25. Consorcio Hospitalario Provincial de Castellón, Avda. Dr. Clará 19, 12002, Castellón, Spain
  • ISSN:1699-3055
文摘
Aim The purpose of the study was to describe infrastructures, treatment modalities, and workload in radiation oncology (RO) in Spain, referred particularly to prostate cancer (PC). Methods An epidemiologic, cross-sectional study was performed during 2008-009. A study-specific questionnaire was sent to the 108 RO-registered departments. Results One hundred and two departments answered the survey, and six were contacted by telephone. Centers operated 236 treatment units: 23 (9.7?%) cobalt machines, 37 (15.7?%) mono-energetic linear accelerators, and 176 (74.6?%) multi-energy linear accelerators. Sixty-one (56.4?%) and 33 (30.5?%) departments, respectively, reported intensity-modulated radiation therapy (IMRT) and image-guided RT (IGRT) capabilities; three-dimensional-conformal RT was used in 75.8?% of patients. Virtual simulators were present in 95 departments (88.0?%), 35 use conventional simulators. Fifty-one departments (47.2?%) have brachytherapy units, 38 (35.2?%) perform prostatic implants. Departments saw a mean of 24.9 new patients/week; the number of patients treated annually was 102,054, corresponding to 88.4?% of patients with a RT indication. In 56.5?% of the hospitals, multidisciplinary teams were available to treat PC. Conclusions Results provide an accurate picture of current situation of RO in Spain, showing a trend toward the progressive introduction of new technologies (IMRT, IGRT, brachytherapy).

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700